GNH USA

Europe — EMA

Odyralduo (Dorzolamide, Timolol)

Dorzolamide, the active ingredient in Odyralduo, is a carbonic anhydrase inhibitor presented as a topical ophthalmic solution for ocular use.

Request sourcing

1
Pack/s

What is Dorzolamide, Timolol?

Dorzolamide, the active ingredient in Odyralduo, is a carbonic anhydrase inhibitor presented as a topical ophthalmic solution for ocular use. It treats elevated intra‑ocular pressure in adults with open‑angle glaucoma or ocular hypertension. GNH USA supplies Odyralduo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Odyralduo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Dorzolamide, Timolol used for?

Odyralduo combines two agents that lower intra‑ocular pressure by acting on the eye's fluid dynamics. It is indicated for: - Open‑angle glaucoma: reduces intra‑ocular pressure to slow disease progression. - Ocular hypertension: lowers pressure to prevent conversion to glaucoma. - Post‑operative ocular pressure spikes: helps control pressure after eye surgery. - Secondary glaucoma: assists in pressure reduction when other causes are present. - Mixed‑mechanism glaucoma: provides additive pressure‑lowering effect when used with other agents. - Chronic glaucoma management: supports long‑term intra‑ocular pressure control.

What are the side effects of Dorzolamide, Timolol?

Odyralduo may cause ocular and systemic adverse reactions.

Common Side Effects: - Burning sensation: burn of the eye at instantiation `````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````` - Eye re‑   a - Reduced  a -  a -  t -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  - Serious or Rare  t  g  ewline

-  t -  t -  d -  a -  a -  a -  -  a -  a -  a -  t -  -  t - \\

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Dorzolamide, Timolol
Route
Ocular Use
Manufacturer
Orifarm Healthcare A/S
Origin
EU

Related products